InvestorsHub Logo
Followers 8
Posts 3893
Boards Moderated 1
Alias Born 06/28/2005

Re: None

Tuesday, 02/06/2007 10:23:52 PM

Tuesday, February 06, 2007 10:23:52 PM

Post# of 45771
New case study: The meth gun- crisis product No. 14

- Recall how it was slowly introduced into the "CDEx suite of products".

- Recall the rumors about DEA contracts (supposedly insider information) designed to draw your attention on the meth gun and away from the hot selling Valimed. (Remember the FAA contract rumor for ELF?)

- Observe how the meth gun has been associated with a national crisis situation like most products before it.

- Recall how CDEX stock promoters began an advertising campaign by posting all meth crisis news on the boards, relevant or not.

- Observe how readers are kept abreast of all available information about Government funding for the new crisis.

- Note how "promotional resources" have slowly turned to the meth gun with Valimed taking a back seat. We now know why.

- Note how news about testing, performance, production... etc is vague or non-existent. No details about the product has always turned out to be bad news.

- Note that the only news so far has been the good news. The good news is the meth gun can detect meth in the lab.

- Watch as beta testing and production milestones keep getting resheduled for "anticipated reasons".

- Note how advertisement about the meth guns performance and targeted markets has become another "30 meter ELF with heads-up display and GPS".

- Watch how the meth gun morphs from the the currently advertised "vision" to the actual production model. (Just like the SafePill 1,2,3,4,5,6...99 became a liquids only Valimed with everything else sheet canned.)

- Watch for the resulting limited niche market where a few prospects will accept delivery just because it's a cool new toy.

- Watch the clever wording in the PR's announcing how the first production units are "sold" into the sizzling hot market place.

The assumption with the above scenario is that the meth gun can make it as far as Valimed. Of course that will take a lot more funding. CDEX better anticipate another 50 million authorized to "getter done" (TM- Closer) and start selling them ASAP. It would appear sales on the last batch started early.






Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.